Innocoll is a bio-pharmaceutical company focusing on targeted drug delivery, primarily in the area of bio-degradable surgical implants.
Business Model:
Revenue: $0
Employees: 11-50
Innocoll Holdings was acquired by
Gurnet Point Capital.
The acquisition happend on 2017-04-04.
Details of the transaction were not public
Address:
City: Ashburn
State: Virginia
Zip:
Country: United States
Innocoll is a privately held international biopharmaceutical company focused on targeted drug delivery primarily in the areas of biodegradable surgical implants and topically applied healthcare products.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/16/2014
Ticker Symbol:
INNL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2012 | Debt Financing | $1.1M | 8/2011 | Debt Financing | $3.3M | 7/2010 | Debt Financing | $5M | 7/2012 | Debt Financing | $2M | 4/2011 | Debt Financing | $3.3M | 4/2009 | Debt Financing | $4M | 1/2014 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
3/2010 | Debt Financing | $4M | 1/2014 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|